1. Home
  2. RAVE vs VERU Comparison

RAVE vs VERU Comparison

Compare RAVE & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

HOLD

Current Price

$3.05

Market Cap

38.5M

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.33

Market Cap

39.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
VERU
Founded
1958
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.5M
39.8M
IPO Year
N/A
1990

Fundamental Metrics

Financial Performance
Metric
RAVE
VERU
Price
$3.05
$2.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.00
AVG Volume (30 Days)
41.4K
170.9K
Earning Date
02-05-2026
12-17-2025
Dividend Yield
N/A
N/A
EPS Growth
9.08
N/A
EPS
0.20
N/A
Revenue
$12,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.12
N/A
Revenue Growth
0.73
N/A
52 Week Low
$2.01
$2.11
52 Week High
$3.75
$14.20

Technical Indicators

Market Signals
Indicator
RAVE
VERU
Relative Strength Index (RSI) 57.09 39.32
Support Level $2.74 $2.17
Resistance Level $2.97 $2.49
Average True Range (ATR) 0.15 0.18
MACD 0.01 0.01
Stochastic Oscillator 57.71 26.42

Price Performance

Historical Comparison
RAVE
VERU

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: